Literature DB >> 6601210

The morbidity and mortality of reoperation for coronary artery disease and analysis of late results with use of actuarial estimate of event-free interval.

H V Schaff, T A Orszulak, B J Gersh, J M Piehler, F J Puga, G K Danielson, J R Pluth.   

Abstract

To determine late survival and functional status after second revascularization procedures for coronary artery disease, we studied 106 consecutive patients operated on between June, 1969, and December, 1980. The mean age of the 96 men and 10 women was 49 +/- 8 years (range 22 to 65 years). Before reoperation, 101 patients (95%) were judged to be in New York Heart Association Class III or IV with angina, and 81 patients (76%) had three-vessel involvement. Angina recurrence was most commonly caused by bypass graft occlusion alone and in combination with progressive disease of the native arteries (60 patients, 57%). Three patients (2.8%) died within 30 days of reoperation; each death resulted from myocardial infarction. An average of 2.2 coronary arteries were bypassed in each patient. Complete follow-up data (mean 43 months) were available for 105 patients. Actuarial survival of patients dismissed alive is 94% at 5 years and 89% at 7 years. All late cardiac-related deaths occurred in patients with three-vessel disease. When recurrence of any angina, need for a third operation, and myocardial infarction are included with cardiac-related deaths, event-free survival is 28% at 5 years and 26% at 7 years. Late survival and functional status could not be predicted by the cause of recurrent angina or the presence of risk factors. Repeat myocardial revascularization can apparently be undertaken with low risk and with prospects for excellent long-term survival. After reoperation, recurrence of mild angina is not uncommon, but freedom from serious cardiac events and relief of severe symptoms were noted in more than 60% of patients 5 years later.

Entities:  

Mesh:

Year:  1983        PMID: 6601210

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Incidence, risk, and outcome of reintervention after aortocoronary bypass surgery.

Authors:  K Laird-Meeter; R van Domburg; M J van den Brand; J Lubsen; E Bos; P G Hugenholtz
Journal:  Br Heart J       Date:  1987-05

2.  State of the vein grafts, native coronary arteries, and myocardium and principal cause of death in patients dying after aortocoronary bypass grafting.

Authors:  A G Rose
Journal:  Thorax       Date:  1985-12       Impact factor: 9.139

3.  Reoperation for angina after previous aortocoronary bypass surgery.

Authors:  J Pidgeon; N Brooks; P Magee; J R Pepper; M F Strurridge; J E Wright
Journal:  Br Heart J       Date:  1985-03

4.  Patient care problems in patients undergoing reoperation for coronary artery grafting surgery.

Authors:  C Brummett; J G Reves; W A Lell; L R Smith
Journal:  Can Anaesth Soc J       Date:  1984-03

5.  Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO).

Authors:  T M Schiele; E Regar; S Silber; E Eeckhout; D Baumgart; W Wijns; A Colombo; W Rutsch; D Meerkin; A Gershlick; R Bonan; P Urban
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

6.  Reoperation for stenotic saphenous vein bypass grafts without cardiopulmonary bypass or shunt.

Authors:  J S Donahoo; H MacVaugh; M J Lechman
Journal:  Tex Heart Inst J       Date:  1986-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.